This Guideline considers problems associated with clinical trials when there are limited numbers of patients available to study. It has been prepared by the CHMP (Committee for Medicinal Products for Human Use) Efficacy Working Party in joint collaboration with members of the Scientific Advice Working Party (SAWP), the Committee on Orphan Medicinal Products (COMP) and the Paediatric Expert Group (PEG).
View this resource Bookmark this resource
EMA Guideline on clinical trials in small populations
Published by European Medicines Agency (EMA)ECRIN
Clinical Trials Toolkit